Sai Life Sciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025.
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences Limited has submitted a certificate to the stock exchange as required under the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2025. This certificate is typically related to the company's compliance with rules around dematerialization (demat) of shares, covering activities such as rematerialization, loss of share certificates, and related depository matters handled during the quarter. No specific financial numbers or material business updates are mentioned in this filing. It is a routine regulatory compliance submission required periodically under SEBI norms. The filing confirms the company is meeting its ongoing disclosure obligations to the exchange.
This is a routine regulatory compliance filing with no material impact on the business, operations, or stock price. Investors should treat it as standard housekeeping disclosure required under SEBI depositary regulations.